Cargando…

Cardiovascular Health Does Not Change Following High-Intensity Interval Training in Women with Polycystic Ovary Syndrome

Introduction: polycystic ovary syndrome (PCOS) is associated with cardiovascular disease (CVD) risk factors. First-line therapy for PCOS is lifestyle changes including exercise. We compared CVD risk factors between women with and without PCOS and examined the responses to high-intensity interval tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiel, Ida Almenning, Jones, Helen, Lionett, Sofie, Røsbjørgen, Ragnhild, Lydersen, Stian, Vanky, Eszter, Moholdt, Trine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953804/
https://www.ncbi.nlm.nih.gov/pubmed/35329952
http://dx.doi.org/10.3390/jcm11061626
_version_ 1784675939911729152
author Kiel, Ida Almenning
Jones, Helen
Lionett, Sofie
Røsbjørgen, Ragnhild
Lydersen, Stian
Vanky, Eszter
Moholdt, Trine
author_facet Kiel, Ida Almenning
Jones, Helen
Lionett, Sofie
Røsbjørgen, Ragnhild
Lydersen, Stian
Vanky, Eszter
Moholdt, Trine
author_sort Kiel, Ida Almenning
collection PubMed
description Introduction: polycystic ovary syndrome (PCOS) is associated with cardiovascular disease (CVD) risk factors. First-line therapy for PCOS is lifestyle changes including exercise. We compared CVD risk factors between women with and without PCOS and examined the responses to high-intensity interval training (HIIT). Methods: women with PCOS were randomized to HIIT (n = 41) or a non-exercise control group (n = 23) for 16 weeks. Women without PCOS (n = 15) were age- and BMI-matched to participants with PCOS and completed 16 weeks of HIIT. CVD markers included blood pressure, heart rate, flow mediated dilatation (FMD), carotid intima-media thickness (IMT), and circulating concentrations of lipids, glucose, insulin, and matrix metalloproteinase-9 (MMP-9). Results: resting heart rate was higher in women with PCOS than without PCOS (p =0.011) and was reduced after HIIT in women with PCOS (−2.8 beats/min, 95% CI: −5.4, −0.2, p = 0.037). FMD was not significantly different between women with PCOS (5.5%, SD 4.1) and those without PCOS (8.2%, SD 3.9) at baseline. HIIT reduced time-to-peak dilatation of the brachial artery in women with PCOS compared with women without PCOS (−55 s, 95% CI: −96, −13, p = 0.012). Conclusions: we found little difference in CVD risk factors between women with and without PCOS at baseline, but some indications of endothelial dysfunction in women with PCOS.
format Online
Article
Text
id pubmed-8953804
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89538042022-03-26 Cardiovascular Health Does Not Change Following High-Intensity Interval Training in Women with Polycystic Ovary Syndrome Kiel, Ida Almenning Jones, Helen Lionett, Sofie Røsbjørgen, Ragnhild Lydersen, Stian Vanky, Eszter Moholdt, Trine J Clin Med Article Introduction: polycystic ovary syndrome (PCOS) is associated with cardiovascular disease (CVD) risk factors. First-line therapy for PCOS is lifestyle changes including exercise. We compared CVD risk factors between women with and without PCOS and examined the responses to high-intensity interval training (HIIT). Methods: women with PCOS were randomized to HIIT (n = 41) or a non-exercise control group (n = 23) for 16 weeks. Women without PCOS (n = 15) were age- and BMI-matched to participants with PCOS and completed 16 weeks of HIIT. CVD markers included blood pressure, heart rate, flow mediated dilatation (FMD), carotid intima-media thickness (IMT), and circulating concentrations of lipids, glucose, insulin, and matrix metalloproteinase-9 (MMP-9). Results: resting heart rate was higher in women with PCOS than without PCOS (p =0.011) and was reduced after HIIT in women with PCOS (−2.8 beats/min, 95% CI: −5.4, −0.2, p = 0.037). FMD was not significantly different between women with PCOS (5.5%, SD 4.1) and those without PCOS (8.2%, SD 3.9) at baseline. HIIT reduced time-to-peak dilatation of the brachial artery in women with PCOS compared with women without PCOS (−55 s, 95% CI: −96, −13, p = 0.012). Conclusions: we found little difference in CVD risk factors between women with and without PCOS at baseline, but some indications of endothelial dysfunction in women with PCOS. MDPI 2022-03-15 /pmc/articles/PMC8953804/ /pubmed/35329952 http://dx.doi.org/10.3390/jcm11061626 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kiel, Ida Almenning
Jones, Helen
Lionett, Sofie
Røsbjørgen, Ragnhild
Lydersen, Stian
Vanky, Eszter
Moholdt, Trine
Cardiovascular Health Does Not Change Following High-Intensity Interval Training in Women with Polycystic Ovary Syndrome
title Cardiovascular Health Does Not Change Following High-Intensity Interval Training in Women with Polycystic Ovary Syndrome
title_full Cardiovascular Health Does Not Change Following High-Intensity Interval Training in Women with Polycystic Ovary Syndrome
title_fullStr Cardiovascular Health Does Not Change Following High-Intensity Interval Training in Women with Polycystic Ovary Syndrome
title_full_unstemmed Cardiovascular Health Does Not Change Following High-Intensity Interval Training in Women with Polycystic Ovary Syndrome
title_short Cardiovascular Health Does Not Change Following High-Intensity Interval Training in Women with Polycystic Ovary Syndrome
title_sort cardiovascular health does not change following high-intensity interval training in women with polycystic ovary syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953804/
https://www.ncbi.nlm.nih.gov/pubmed/35329952
http://dx.doi.org/10.3390/jcm11061626
work_keys_str_mv AT kielidaalmenning cardiovascularhealthdoesnotchangefollowinghighintensityintervaltraininginwomenwithpolycysticovarysyndrome
AT joneshelen cardiovascularhealthdoesnotchangefollowinghighintensityintervaltraininginwomenwithpolycysticovarysyndrome
AT lionettsofie cardiovascularhealthdoesnotchangefollowinghighintensityintervaltraininginwomenwithpolycysticovarysyndrome
AT røsbjørgenragnhild cardiovascularhealthdoesnotchangefollowinghighintensityintervaltraininginwomenwithpolycysticovarysyndrome
AT lydersenstian cardiovascularhealthdoesnotchangefollowinghighintensityintervaltraininginwomenwithpolycysticovarysyndrome
AT vankyeszter cardiovascularhealthdoesnotchangefollowinghighintensityintervaltraininginwomenwithpolycysticovarysyndrome
AT moholdttrine cardiovascularhealthdoesnotchangefollowinghighintensityintervaltraininginwomenwithpolycysticovarysyndrome